Medicare Enrolled
Nelson Medina Villanueva
Critical Care Medicine · Kissimmee, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Medina Villanueva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Medina Villanueva?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Medina Villanueva
Nelson Medina Villanueva is a critical care medicine specialist in Kissimmee, FL, with 16 years of NPI registration. Based on federal Medicare data, Medina Villanueva performed 1,249 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Medina Villanueva received a total of $13,387 from 41 pharmaceutical and/or device companies across 521 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Medina Villanueva is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 28% volume in FL
$13,387 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 119501 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,249
Medicare services
Top 28% in FL for critical care medicine
Not available
Unique patients (not deduplicated)
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
606 | $95 | $230 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
126 | $166 | $620 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
107 | $65 | $145 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
79 | $140 | $388 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
63 | $19 | $73 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
51 | $40 | $109 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
47 | $41 | $108 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $101 | $215 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
42 | $64 | $148 |
| New patient office visit, complex (60-74 min) | 29 | $152 | $414 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $103 | $266 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $142 | $288 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
12 | $107 | $316 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$13,387
Total received (2018-2024)
Avg $1,912/year across 7 years
Top 15% in FL for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
521
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,389
2023
$2,143
2022
$1,783
2021
$1,847
2020
$1,192
2019
$1,900
2018
$2,133
Payments by company (2024)
GlaxoSmithKline, LLC.
$665
AstraZeneca Pharmaceuticals LP
$415
Grifols USA, LLC
$220
Amgen Inc.
$152
Regeneron Healthcare Solutions, Inc.
$144
GENZYME CORPORATION
$138
JAZZ PHARMACEUTICALS INC.
$137
Actelion Pharmaceuticals US, Inc.
$122
Electromed, Inc.
$92
Takeda Pharmaceuticals U.S.A., Inc.
$60
Insmed, Inc.
$57
Mylan Specialty L.P.
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
Genentech USA, Inc.
$23
HARMONY BIOSCIENCES LLC
$22
Baxter Healthcare
$21
Axsome Therapeutics, Inc.
$20
Hikma Pharmaceuticals USA
$16
Top 3 companies account for 54.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,187
AstraZeneca Pharmaceuticals LP
$2,506
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,280
Regeneron Healthcare Solutions, Inc.
$647
Grifols USA, LLC
$528
Actelion Pharmaceuticals US, Inc.
$504
United Therapeutics Corporation
$407
JAZZ PHARMACEUTICALS INC.
$381
Mylan Specialty L.P.
$321
GENZYME CORPORATION
$282
Takeda Pharmaceuticals U.S.A., Inc.
$240
E.R. Squibb & Sons, L.L.C.
$221
Allergan, Inc.
$211
Genentech USA, Inc.
$205
Amgen Inc.
$202
Insmed, Inc.
$171
Paratek Pharmaceuticals, Inc.
$170
HARMONY BIOSCIENCES LLC
$164
Electromed, Inc.
$164
Bayer HealthCare Pharmaceuticals Inc.
$161
Sunovion Pharmaceuticals Inc.
$157
Vapotherm Inc
$147
Jazz Pharmaceuticals Inc.
$144
Astute Medical, Inc.
$126
PFIZER INC.
$125
IDORSIA PHARMACEUTICALS US INC
$125
Philips Electronics North America Corporation
$109
Theravance Biopharma, Inc.
$105
Harmony Biosciences LLC
$74
Baxter Healthcare
$64
Ceribell, Inc.
$50
Shire North American Group Inc
$47
Hikma Pharmaceuticals USA
$31
ANI Pharmaceuticals, Inc.
$27
Axsome Therapeutics, Inc.
$20
Novartis Pharmaceuticals Corporation
$19
Janssen Pharmaceuticals, Inc
$16
Teva Pharmaceuticals USA, Inc.
$15
Advanced Respiratory, Inc
$14
Circassia Pharmaceuticals Inc
$14
Inogen, Inc.
$9
Top 3 companies account for 52.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CUVITRU · Ceribell Rapid Response EEG · DALIRESP · DUPIXENT · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · InogenOne · LONHALA MAGNAIR · NEXIUM · NIOX VERO · NUCALA · NUZYRA · Nephrocheck · OFEV · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Precision Flow · Prolastin-C Liquid · QUVIVIQ · Ryaltris · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · VIBATIV · WAKIX · Wakix · XARELTO · XOLAIR · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Critical care medicines in nearby ZIP areas
75
County median income
$68,711
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA POINCIANA HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Medina Villanueva is a clinical cardiology specialist, with above-average Medicare volume (top 28% in FL), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Medina Villanueva experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Medina Villanueva performed 606 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Medina Villanueva receive payments from pharmaceutical companies?
Yes. Medina Villanueva received a total of $13,387 from 41 companies across 521 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Medina Villanueva's costs compare to other critical care medicines in Kissimmee?
Medina Villanueva's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Medina Villanueva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Kissimmee
Browse critical care medicines in Kissimmee ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in FL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in FL
Which FL critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology